Keywords: Merck KGaA, EMD Serono, Pfizer, Rebif Rebidose, USA, FDA, Multiple sclerosis

US FDA approves Merck KGaA's Rebif Rebidose

Article | 04 January 2013

Print This

German drug major Merck KGaA’s (MRK: DE) US subsidiary EMD Serono and pharma behemoth Pfizer (NYSE: PFE) yesterday ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in